Covid-19 vaccine compliance among residents of Kathmandu Valley
DOI:
https://doi.org/10.62992/ijphap.v2i3.48Keywords:
COVID-19 vaccine, Prior vaccination history, Risk perception, Vaccine complianceAbstract
Background: The Coronavirus disease 2019 (COVID-19) pandemic is a public health threat. Equitable access to safe and effective vaccines is critical to end the COVID-19 pandemic. Promoting the uptake of vaccines (particularly those against COVID-19) require the understanding whether people are willing to be vaccinated, and the reasons behind their decision.
Objectives: This study aimed to assess COVID-19 vaccine compliance and factors associated with it among residents of Kathmandu valley.
Methods: A cross-sectional analytical study was conducted among residents of Kathmandu valley through a pre-tested web-based self-administered questionnaire. A total of 390 respondents were selected to carry out this study. The collected data were entered into MS-excel and analyzed using SPSS IBM v. 25. Multivariable analysis was performed.
Results: Vaccine compliance was found in 94.1% of 390 respondents. Among the respondents, 91.5% had low risk perception of COVID-19; 85.4% had complete prior vaccination history; 61.3% perceived COVID-19 vaccine as effective; 65.6% perceived. COVID-19 vaccine as necessary whereas only 24.6 % believed the COVID-19 vaccine to be safe. Regarding COVID-19 vaccine compliance, females demonstrated a 3-fold higher likelihood than males (AOR= 3.0, 95%CI: 1.01-9.21). Complete vaccination history which had 31.9 times higher odds than no vaccination history (AOR=31.96, 95%CI: 9.72-105.14), perceived vaccine effectiveness which had 7.7 times higher odds than perceived ineffective (AOR= 7.75, 95%CI: 2.37-25.38), and high social influence which had 7.7 times higher odds compared to low social influence (AOR= 7.72, 95%CI: 2.19-27.12) were the associated factors with increased compliance.
Conclusion: This study revealed significantly high vaccine compliance rate in Kathmandu valley. Sex, complete vaccination history, perceived vaccine effectiveness and high social influence were the determinants for vaccine compliance which indicated the importance of ensuring people trust the vaccine's safety, utilizing social influence to encourage vaccination, and tailoring strategies to suit different demographics.
References
Worldometer. COVID Live Update: 244,509,655 Cases and 4,965,586 Deaths from the Coronavirus - Worldometer 2021 [Available from: https://www.worldometers.info/coronavirus/#countries.
WHO. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus 2019 (n-CoV) on 23 January 2020 2020 [Available from: https://www.who.int/news/item/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
Anderson RM, Vegvari C, Truscott J, Collyer BSJTL. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. 2020;396(10263):1614-6.
Billah MA, Miah MM, Khan MNJPo. Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence. 2020;15(11):e0242128.
Britton T, Ball F, Trapman PJs. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2. 2020;369(6505):846-9.
Harrison EA, Wu JWJEjoe. Vaccine confidence in the time of COVID-19. 2020;35(4):325-30.
Palamenghi L, Barello S, Boccia S, Graffigna GJEjoe. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. 2020;35:785-8.
Juhani E, Liang X, Reingold A, Chaudhuri M, Dubé E, Gellin B, Goldstein S, Larson H, et al. Report of the SAGE working group on vaccine hesitancy. 2014.
WHO. Global research on coronavirus disease (COVID-19): World Health Organization; 2021 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov.
Habersaat KB, Betsch C, Danchin M, Sunstein CR, Böhm R, Falk A, Brewer NT, Omer SB, et al. Ten considerations for effectively managing the COVID-19 transition. 2020;4(7):677-87.
Weintraub RL, Subramanian L, Karlage A, Ahmad I, Rosenberg JJHA. COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now: Analysis describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery for COVID-19. 2021;40(1):33-41.
Yadav R, Khatri E, Marahatta S, Yadav D, Baral Y, Poudyal J. Attitude and Perception of Young Adults Regarding. 2021.
Han Q, Lin Q, Ni Z, You LJI, Viruses OR. Uncertainties about the transmission routes of 2019 novel coronavirus. 2020;14(4):470.
Gaire A, Panthee B, Basyal D, Paudel A, Panthee SJC. COVID-19 vaccine acceptance: a case study from Nepal. 2022;2(8):1014-25.
Machingaidze S, Wiysonge CSJNm. Understanding COVID-19 vaccine hesitancy. 2021;27(8):1338-9.
Gowda C, Dempsey AFJHv, immunotherapeutics. The rise (and fall?) of parental vaccine hesitancy. 2013;9(8):1755-62.
MacDonald NEJV. Vaccine hesitancy: Definition, scope and determinants. 2015;33(34):4161-4.
Lau BHP, Yuen SWH, Yue RPH, Grépin KAJPh. Understanding the societal factors of vaccine acceptance and hesitancy: evidence from Hong Kong. 2022;207:39-45.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 International Journal of Public Health Asia Pacific
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
International Journal of Public Health Asia Pacific (IJPHAP) is licensed under a Creative Commons Attribution-Non Commercial-No Derivatives 4.0 international (CC BY-NC-ND 4.0) license, unless otherwise stated. Please read our Policies page for more information on Open Access, copyright, and permissions.
